SIRACUSA, MASSIMILIANO
 Distribuzione geografica
Continente #
EU - Europa 2.060
NA - Nord America 1.491
AS - Asia 837
SA - Sud America 254
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 4.684
Nazione #
US - Stati Uniti d'America 1.459
RU - Federazione Russa 1.052
SG - Singapore 320
CN - Cina 252
IE - Irlanda 218
BR - Brasile 212
SE - Svezia 199
IT - Italia 188
DE - Germania 112
HK - Hong Kong 93
FR - Francia 70
FI - Finlandia 54
VN - Vietnam 51
GB - Regno Unito 43
IN - India 42
PL - Polonia 36
UA - Ucraina 22
CA - Canada 16
BD - Bangladesh 15
AT - Austria 14
ZA - Sudafrica 11
AR - Argentina 10
BE - Belgio 10
CO - Colombia 10
NL - Olanda 10
IQ - Iraq 8
JP - Giappone 8
MX - Messico 8
CI - Costa d'Avorio 7
CZ - Repubblica Ceca 7
ES - Italia 7
PK - Pakistan 6
BO - Bolivia 5
CL - Cile 5
ID - Indonesia 5
MA - Marocco 5
TR - Turchia 5
EC - Ecuador 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DZ - Algeria 3
IR - Iran 3
LT - Lituania 3
MK - Macedonia 3
PS - Palestinian Territory 3
PY - Paraguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
XK - ???statistics.table.value.countryCode.XK??? 3
CH - Svizzera 2
CR - Costa Rica 2
EU - Europa 2
JO - Giordania 2
KE - Kenya 2
KW - Kuwait 2
NG - Nigeria 2
PA - Panama 2
QA - Qatar 2
RO - Romania 2
SA - Arabia Saudita 2
AO - Angola 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KI - Kiribati 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
MM - Myanmar 1
MY - Malesia 1
NI - Nicaragua 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.684
Città #
Ashburn 268
Moscow 264
Dublin 218
Chandler 213
Singapore 193
Dallas 182
Nyköping 110
Hong Kong 93
Beijing 88
Messina 60
San Jose 57
The Dalles 55
Jacksonville 51
Munich 40
Warsaw 34
Lauterbourg 33
Dearborn 29
Los Angeles 29
Princeton 28
Medford 25
Turku 23
Des Moines 22
New York 22
Bremen 21
Hyderabad 20
Cambridge 19
Ho Chi Minh City 17
Council Bluffs 14
Tianjin 13
Redondo Beach 11
Vienna 11
Brussels 10
Hanoi 10
Helsinki 10
Jinan 10
Orem 10
São Paulo 10
Boardman 9
Brooklyn 9
Frankfurt am Main 9
Bologna 8
Buffalo 8
Johannesburg 8
Lancaster 8
San Mateo 8
Shenyang 8
Tokyo 8
Abidjan 7
Belo Horizonte 7
Guangzhou 7
London 7
Montreal 7
Nuremberg 7
Pune 7
Bexley 6
Dong Ket 6
Hangzhou 6
Hebei 6
Rio de Janeiro 6
Taizhou 6
Washington 6
Woodbridge 6
Ann Arbor 5
Chicago 5
Denver 5
Manchester 5
Nanjing 5
San Francisco 5
Santa Clara 5
Vittoria 5
Wilmington 5
Atlanta 4
Brasília 4
Changsha 4
Chennai 4
Düsseldorf 4
Fuzhou 4
Malnate 4
Mazzarrone 4
Medellín 4
Milazzo 4
Nürnberg 4
Toronto 4
Ardabil 3
Baghdad 3
Boston 3
Brno 3
Buenos Aires 3
Charlotte 3
Goiânia 3
Hillsboro 3
Houston 3
Jakarta 3
Leawood 3
Milan 3
Mumbai 3
Nanchang 3
Olomouc 3
Pelotas 3
Phoenix 3
Totale 2.647
Nome #
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 269
Radioterapia Stereotassica ad alte dosi mediante sistema IGRT. Puo' migliorare il controllo locale di malattia e la sopravvivenza nei pazienti con oligometastasi? 208
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI 196
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 187
99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 187
IMAGE-GUIDED RADIOTHERAPY (IGRT; oF THE CYBERKNIFE RADIOSURGERY FOR TREATING OPTIC AND PERIOPTIC LESIONS. 181
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 177
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 176
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 174
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 170
HER2 analysis in sporadic thyroid cancer of follicular cell origin 169
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario 166
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 164
Evoluzione tecnologica nel trattamento radiochirurgico delle metastasi cerebrali. Esperienza decennale del Centro di Messina. 160
CyberKnife Radiosurgery Alone or Combined with "Dose Dense" Temozolomide Administration for Recurrent Gliomas. 159
STEREOTACTIC ROBOTIC RADIOSURGERY IN THE MANAGEMENT OF PALLIATIVE RADIOSURGERY FOR BRAIN METASTASES: A RETROSPECTIVE ANALYSIS. 152
RADIOSURGERY FOR SINGLE SPINALMETASTASES COMBINING DOUBLE DOSE WITHIGRT MODALITY. PRELIMINARY EXPERIENCE 152
Radiobiological and clinical evalutation of retreatment for spinal bone metastases following different fractionation schemes 151
BRAFV600E and 99mTc-MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy 150
Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer 147
ESPERIENZA DEL TRATTAMENTO ADIUVANTE DEL CARCINOMA GASTRICO. STADIO DI MALATTIA E CAMPO DITRATTAMENTO 146
VALUTAZIONE COMPARATIVA SU BASE RADIOBIOLOGICA DEGLI EFFETTI DOSE-VOLUME SUL MIDOLLO SPINALE SOTTOPOSTOA REGIMI DI TRATTAMENTO RADIANTE IPOFRAZIONATI UTILIZZANDO IL MODELLO LINEARE QUADRATICO STANDARD ED ILMODELLO LINEARE QUADRATICO IBRIDO 146
Hepatocyte growth factor/C-met axis in thyroid cancer: From diagnostic biomarker to therapeutic target 142
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy in a real-life scenario 117
Malignant thyroid nodule topography as additional risk factor for lymph-node metastases in differentiated thyroid cancer patients 108
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study 108
Thyroid Cancer Persistence in Patients with Unreliable Thyroglobulin Measurement: Circulating microRNA as Candidate Alternative Biomarkers 92
Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative 131I Administration: A Real Life Study 90
BRAF (V600E) mutation in isthmic malignant thyroid nodules 89
Usefulness of 123I-spect/ct to assess the response to initial therapy in differentiated thyroid cancer patients 65
SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives 53
Thyroglobulin Value Predict Iodine-123 Imaging Result in Differentiated Thyroid Cancer Patients 48
Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic 29
null 26
Nodal metastasis in noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) 19
Oldie but Goldie: The Fundamental Role of Radioiodine in the Management of Thyroid Cancer 1
Totale 4.774
Categoria #
all - tutte 14.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.725


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 0 0 0 0 25 19 12
2021/2022236 1 23 3 11 7 2 11 5 2 53 42 76
2022/2023699 55 82 36 57 59 78 12 34 264 0 17 5
2023/2024223 12 25 8 25 20 46 9 31 0 21 12 14
2024/2025759 20 14 9 35 37 34 25 109 170 66 101 139
2025/20262.318 144 153 183 160 176 446 270 335 337 114 0 0
Totale 4.774